0.9201
price down icon5.95%   -0.0582
after-market アフターアワーズ: .92 -0.000100 -0.01%
loading
前日終値:
$0.9783
開ける:
$0.9805
24時間の取引高:
471.66K
Relative Volume:
0.75
時価総額:
$97.18M
収益:
$100.56M
当期純損益:
$-119.05M
株価収益率:
-0.748
EPS:
-1.23
ネットキャッシュフロー:
$-231.16M
1週間 パフォーマンス:
+1.75%
1か月 パフォーマンス:
-33.33%
6か月 パフォーマンス:
-82.13%
1年 パフォーマンス:
-81.85%
1日の値動き範囲:
Value
$0.913
$1.03
1週間の範囲:
Value
$0.90
$1.085
52週間の値動き範囲:
Value
$0.87
$6.78

Alector Inc Stock (ALEC) Company Profile

Name
名前
Alector Inc
Name
セクター
Healthcare (1151)
Name
電話
415-231-5660
Name
住所
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Name
職員
238
Name
Twitter
Name
次回の収益日
2024-12-05
Name
最新のSEC提出書
Name
ALEC's Discussions on Twitter

ALEC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ALEC
Alector Inc
0.9201 97.18M 100.56M -119.05M -231.16M -1.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Alector Inc Stock (ALEC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-17 ダウングレード Mizuho Outperform → Neutral
2024-12-16 ダウングレード Stifel Buy → Hold
2024-12-04 ダウングレード BofA Securities Neutral → Underperform
2024-11-29 繰り返されました H.C. Wainwright Buy
2024-11-26 ダウングレード Morgan Stanley Equal-Weight → Underweight
2023-12-14 アップグレード Stifel Hold → Buy
2023-12-12 開始されました Deutsche Bank Buy
2023-09-25 開始されました Goldman Sell
2023-09-22 開始されました Cantor Fitzgerald Overweight
2023-01-06 ダウングレード BofA Securities Buy → Neutral
2022-09-09 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-07-07 開始されました Mizuho Buy
2022-04-13 開始されました Goldman Sell
2022-03-08 ダウングレード Stifel Buy → Hold
2021-09-27 開始されました William Blair Outperform
2021-01-15 再開されました BofA Securities Buy
2020-06-24 開始されました H.C. Wainwright Buy
2020-04-28 開始されました Goldman Buy
2020-03-06 開始されました Citigroup Buy
2020-02-27 開始されました Barclays Overweight
2020-02-19 開始されました Stifel Buy
2019-11-21 開始されました BTIG Research Buy
2019-03-04 開始されました Barclays Overweight
2019-03-04 開始されました BofA/Merrill Buy
2019-03-04 開始されました Morgan Stanley Overweight
2019-03-04 開始されました SVB Leerink Outperform
すべてを表示

Alector Inc (ALEC) 最新ニュース

pulisher
07:02 AM

What Analysts Were Expecting After Alector Inc (NASDAQ: ALEC) fell -5.95% - stocksregister.com

07:02 AM
pulisher
Apr 17, 2025

Alector Completes Enrollment for Phase 2 Alzheimer's Trial of AL101 - MarketScreener

Apr 17, 2025
pulisher
Apr 17, 2025

Alector Announces Completion of Enrollment in the - GlobeNewswire

Apr 17, 2025
pulisher
Apr 17, 2025

Alector (ALEC) Completes Enrollment for Alzheimer's Drug Trial | ALEC Stock News - GuruFocus

Apr 17, 2025
pulisher
Apr 17, 2025

Major Milestone: Alector's Innovative Alzheimer's Drug Trial Hits Full Enrollment Ahead of Schedule - Stock Titan

Apr 17, 2025
pulisher
Apr 07, 2025

Alector stock hits 52-week low at $0.99 amid sharp decline By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Alector stock hits 52-week low at $0.99 amid sharp decline - Investing.com India

Apr 07, 2025
pulisher
Apr 04, 2025

Alector, Inc. (NASDAQ:ALEC) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Apr 04, 2025
pulisher
Apr 03, 2025

Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com

Apr 03, 2025
pulisher
Apr 03, 2025

Frontotemporal Dementia Pipeline 2025: Key Companies, MOA, - openPR.com

Apr 03, 2025
pulisher
Apr 03, 2025

Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World

Apr 03, 2025
pulisher
Mar 31, 2025

Alector stock hits 52-week low at $1.24 amid market challenges - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

Charles Schwab Investment Management Inc. Reduces Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Alector, Inc. (NASDAQ:ALEC) Shares Sold by Charles Schwab Investment Management Inc. - The AM Reporter

Mar 30, 2025
pulisher
Mar 28, 2025

Alector Announces Resignation of Chief Medical Officer - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Appoints New Chief Medical Officer - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Provides Executive Leadership Update - The Manila Times

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Names Neurology Expert as CMO Amid Crucial Phase 3 Dementia Trial - Stock Titan

Mar 28, 2025
pulisher
Mar 25, 2025

Alector Cuts Staff Again, This Time Laying Off 13% of Workforce - BioSpace

Mar 25, 2025
pulisher
Mar 21, 2025

Alector, Inc. (NASDAQ:ALEC) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st

Mar 21, 2025
pulisher
Mar 19, 2025

Alector stock hits 52-week low at $1.29 amid sharp annual decline - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments - Investing.com

Mar 18, 2025
pulisher
Mar 13, 2025

Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection Point (NASDAQ:ALEC) - Seeking Alpha

Mar 13, 2025
pulisher
Mar 12, 2025

Mizuho’s latest rating for ALEC stock - Knox Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Alector at Leerink Global Healthcare Conference: Strategic Advances in Neurodegeneration - Investing.com India

Mar 11, 2025
pulisher
Mar 10, 2025

Alector announces workforce reduction to cut costs By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Alector announces workforce reduction to cut costs - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

Alector to Cut 13% of Workforce - MarketWatch

Mar 10, 2025
pulisher
Mar 10, 2025

Have Alector Insiders Been Selling Stock? - simplywall.st

Mar 10, 2025
pulisher
Mar 09, 2025

Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Consensus Target Price from Analysts - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Alector assumed with an Underweight at Morgan Stanley - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies By Investing.com - Investing.com UK

Mar 06, 2025
pulisher
Mar 05, 2025

Alector Executives Sell Shares to Satisfy Tax Obligations - TradingView

Mar 05, 2025
pulisher
Mar 04, 2025

Alector stock hits 52-week low at $1.54 amid sharp annual decline - Investing.com Australia

Mar 04, 2025
pulisher
Mar 04, 2025

HC Wainwright Brokers Raise Earnings Estimates for Alector - The AM Reporter

Mar 04, 2025
pulisher
Mar 03, 2025

Alector stock hits 52-week low at $1.54 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 02, 2025

Research Analysts Set Expectations for Alector Q1 Earnings - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

HC Wainwright Reiterates “Buy” Rating for Alector (NASDAQ:ALEC) - The AM Reporter

Mar 02, 2025
pulisher
Mar 01, 2025

Earnings Update: Alector, Inc. (NASDAQ:ALEC) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St

Mar 01, 2025
pulisher
Feb 28, 2025

Alector (NASDAQ:ALEC) Receives "Buy" Rating from HC Wainwright - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Alector Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

Alector’s Earnings Call: Progress Amid Challenges - TipRanks

Feb 27, 2025

Alector Inc (ALEC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Alector Inc (ALEC) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Rosenthal Arnon
Chief Executive Officer
Mar 03 '25
Sale
1.47
40,330
59,176
2,466,744
GRASSO MARC
Chief Financial Officer
Mar 03 '25
Sale
1.47
18,091
26,547
312,560
Romano Gary
Chief Medical Officer
Mar 03 '25
Sale
1.47
16,306
23,927
332,977
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
大文字化:     |  ボリューム (24 時間):